key: cord-0801654-vcenh7d7
authors: Salkapuram, Sunil Kumar; Elumalai, Karthikeyan
title: Aged diabetic amputee with COVID-19: A medication therapy
date: 2022-02-23
journal: Chronic Dis Transl Med
DOI: 10.1016/j.cdtm.2022.02.005
sha: f286a2ae5f926272e7745738aefbada9eba47701
doc_id: 801654
cord_uid: vcenh7d7

nan

has a very detrimental impact on people who have disease problems or who are elderly, and it can potentially cause death. 2 According to research, diabetics are more prone to infectious illnesses, particularly those of bacterial and viral origin, and this, in turn, leads to an uncontrolled immune response. 3 The majority of studies point to a lack of immunological response as a cause of diabetes risk. 4 In SARS patients, diabetes mellitus (DM) is regularly identified as a separate risk factor for respiratory tract infections, morbidity, and death. 5 In comparison to other causes of respiratory disease, the coronavirus has gotten a lot of attention, especially following the SARS and MERS epidemics. In terms of risk factors, clinical symptoms, and clinical outcomes, the COVID-19 was identical to SARS and MERS.

The diabetic amputee's COVID-19 rehabilitation was treated with specific symptomatic and supportive therapy, according to this case report, and he was discharged after 22 days.

For the preceding four days, an 80 year old diabetic man with a recent right little toe amputation presented to the Santhiram general hospital with a dry cough, sinus congestion, and intermittent fever. After obtaining a nasopharyngeal swab sample and doing a COVID profile test, he was found to be COVID-19 positive. In addition, a CT chest was performed for confirmation of SARA COV-2 viral lung invasion. On CT, there was no evidence of COVID-19 (CO-RADS 3). He was placed in the COVID-19 isolation ward as a result.

He has been diagnosed as a diabetic for the past nine years, with irregular medication and insulin therapy. He had never experienced hypertension before. The patient had type-II diabetes mellitus (DM), which had gone untreated and resulted in severe cellulitis that was resistant to antibiotics. The toe was removed due to the severity of the ailment. The wound region had also shown signs of tissue development. Regular dressings, as well as continuing insulin medication and antibiotics, were used to treat it. Glyburide 5 mg twice daily tablet, WBC count was 11,000 cells/cu.mm, the differential count of neutrophils was 58 percent, lymphocytes were 55 percent, eosinophils were 1%, and monocytes were 10%, according to laboratory data. The basophil count was 1%, the hematocrit was 45%, and the platelet count In recent decades, diabetes mellitus has become more frequent, posing a global health issue. 6 In this case, the patient had an underlying health condition, such as being older; diabetes with amputation was considered a high risk factor for the novel coronavirus affecting the patient; and the patient had symptoms such as fever, dry cough, and nasal congestion. If the suggestion for hospital admission is delayed, the severity of the patient's illness may worsen. COVID-19. 7 according to previous research, causes more difficulties and mortality among older diabetics. Patients with chronic conditions, particularly those with diabetes and diabetic foot ulceration and amputation, were greatly aggravated by the mandated lockdown, putting a significant strain on healthcare services in terms of death and reduced quality of life. 8 In this case, the levels of Interleukin-6, D-Dimer, and serum LDH increased, whereas the levels of HS Troponin, Ferritin, and CRP remained normal. The elevated D-Dimer readings could imply that the hypercoagulable state is linked to a greater mortality rate in COVID-19. 9 A decreased immune response is caused by increased inflammatory serum levels, such as IL-6.

In type 2 diabetes patients, both insulin and antidiabetic medications have proved to have optimal glucose-lowering and anti-inflammatory effects, and may be a feasible therapeutic choice for the treatment of asymptomatic and non-critically ill diabetic patients with COVID-19. 10 The COVID-19 was treated symptomatically with Hydroxychloroquine, Azithromycin, antipyretics, and a combination of Phenylephrine Chlorpheniramine and Dextromethorphan, as well as antihyperglycemic agents, Insulin, and supplements such as Vitamin D3, Zinc, and antioxidants, to prevent further complications and increase clinical efficacy.

COVID-19 is a pandemic that is spreading quickly. One of the most common complications in COVID-19 patients is type 2 diabetes, which is an independent predictor of poor outcomes.

Because hyperglycemia and hypoglycemia are connected to an elevated inflammatory profile and acute coronary events, rigorous glucose management is critical. For non-critical diabetic or diabetic Amputees with COVID-19, successful glucose lowering, anti-inflammatory effects, and effective diabetic foot care, both insulin and antidiabetic medicines alone or in combination, can be a realistic therapeutic choice. The government's social isolation and other COVID-19 infection prevention measures are recommended for diabetic patients with complications. Because his little right toe has already been removed, educating the patient on correct foot care, avoiding further infection exposure, and preventing COVID-19 is a vital work role in this case.

None.

Coronavirus disease (COVID-19) and immunity booster green foods: A mini review

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

COVID-19: consider cytokine storm syndromes and immunosuppression

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without Diabetes: A systematic search and a narrative J o u r n a l P r e -p r o o f review with a special reference to India and other developing countries

Clinical considerations for patients with diabetes in times of COVID-19 epidemic

High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Guillain-Barré syndrome associated with SARS-CoV-2

A novel coronavirus from patients with pneumonia in China

Beware of the second wave of COVID-19